Martin Kornacker
5PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.Maria Vieito, Elisa Fontana, Catherine H Han
|May 18, 2022
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.Ester Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl
|Nov 16, 2021
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor.Jürgen Wichmann, Caroline Rynn, Thomas Friess
|Sep 28, 2021
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma.Michael Dickinson, Javier Briones, Alex F Herrera
Pageof 1
Frequent Collaborators
3 joint publications
Gabriel Schnetzler
2 joint publications
Christina Godfried Sie
2 joint publications
Jasmin Emmenegger
2 joint publications
Reinhard Dummer
1 joint publications
Nino Keshelava
1 joint publications
Ajay Nooka
1 joint publications
Sascha A Tuchman
1 joint publications
Jacob Laubach
1 joint publications
Michael Dickinson
1 joint publications
Alex F Herrera
